|
1
|
Rinn JL and Chang HY: Genome regulation by
long noncoding RNAs. Annu Rev Biochem. 81:145–166. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Huang JZ, Chen M, Chen D, Gao XC, Zhu S,
Huang H, Hu M, Zhu H and Yan GR: A peptide encoded by a putative
lncRNA HOXB-AS3 suppresses colon cancer growth. Mol Cell.
68:171–184.e6. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Jackson R, Kroehling L, Khitun A, Bailis
W, Jarret A, York AG, Khan OM, Brewer JR, Skadow MH, Duizer C, et
al: The translation of non-canonical open reading frames controls
mucosal immunity. Nature. 564:434–438. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Stein LD: Human genome: End of the
beginning. Nature. 431:915–916. 2004. View
Article : Google Scholar : PubMed/NCBI
|
|
5
|
Mercer TR, Dinger ME and Mattick JS: Long
non-coding RNAs: Insights into functions. Nat Rev Genet.
10:155–159. 2009. View
Article : Google Scholar : PubMed/NCBI
|
|
6
|
Struhl K: Transcriptional noise and the
fidelity of initiation by RNA polymerase II. Nat Struct Mol Biol.
14:103–105. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Ebisuya M, Yamamoto T, Nakajima M and
Nishida E: Ripples from neighbouring transcription. Nat Cell Biol.
10:1106–1113. 2008. View
Article : Google Scholar : PubMed/NCBI
|
|
8
|
Ponting CP, Oliver PL and Reik W:
Evolution and functions of long noncoding RNAs. Cell. 136:629–641.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Bian Z, Jin L, Zhang J, Yin Y, Quan C, Hu
Y, Feng Y, Liu H, Fei B, Mao Y, et al: LncRNA-UCA1 enhances cell
proliferation and 5-fluorouracil resistance in colorectal cancer by
inhibiting miR-204-5p. Sci Rep. 6:238922016. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Pauli A, Rinn JL and Schier AF: Non-coding
RNAs as regulators of embryogenesis. Nat Rev Genet. 12:136–149.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Yang SZ, Xu F, Zhou T, Zhao X, McDonald JM
and Chen Y: The long non-coding RNA HOTAIR enhances pancreatic
cancer resistance to TNF-related apoptosis-inducing ligand. J Biol
Chem. 292:10390–10397. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Schmitt AM and Chang HY: Long noncoding
RNAs in cancer pathways. Cancer Cell. 29:452–463. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Batista PJ and Chang HY: Long noncoding
RNAs: Cellular address codes in development and disease. Cell.
152:1298–1307. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Guttman M and Rinn JL: Modular regulatory
principles of large non-coding RNAs. Nature. 482:339–346. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Khaitan D, Dinger ME, Mazar J, Crawford J,
Smith MA, Mattick JS and Perera RJ: The melanoma-upregulated long
noncoding RNA SPRY4-IT1 modulates apoptosis and invasion. Cancer
Res. 71:3852–3862. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Wang Y, Xia Y and Lu Z: Metabolic features
of cancer cells. Cancer Commun (Lond). 38:652018. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Warburg O, Wind F and Negelein E: The
metabolism of tumors in the body. J Gen Physiol. 8:519–530. 1927.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Yang F, Zhang H, Mei Y and Wu M:
Reciprocal regulation of HIF-1α and lincRNA-p21 modulates the
Warburg effect. Mol Cell. 53:88–100. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Li X, Zhao Q, Qi J, Wang W, Zhang D, Li Z
and Qin C: lncRNA Ftx promotes aerobic glycolysis and tumor
progression through the PPARγ pathway in hepatocellular carcinoma.
Int J Oncol. 53:551–566. 2018.PubMed/NCBI
|
|
20
|
Yang X, Ye H, He M, Zhou X, Sun N, Guo W,
Lin X, Huang H, Lin Y, Yao R and Wang H: LncRNA PDIA3P interacts
with c-Myc to regulate cell proliferation via induction of pentose
phosphate pathway in multiple myeloma. Biochem Biophys Res Commun.
498:207–213. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Li W, Huang K, Wen F, Cui G, Guo H, He Z
and Zhao S: LINC00184 silencing inhibits glycolysis and restores
mitochondrial oxidative phosphorylation in esophageal cancer
through demethylation of PTEN. EBioMedicine. 44:298–310. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Redis RS, Vela LE, Lu W, Ferreira de
Oliveira J, Ivan C, Rodriguez-Aguayo C, Adamoski D, Pasculli B,
Taguchi A, Chen Y, et al: Allele-specific reprogramming of cancer
metabolism by the long non-coding RNA CCAT2. Mol Cell. 61:520–534.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Wei S, Fan Q, Yang L, Zhang X, Ma Y, Zong
Z, Hua X, Su D, Sun H, Li H and Liu Z: Promotion of glycolysis by
HOTAIR through GLUT1 upregulation via mTOR signaling. Oncol Rep.
38:1902–1908. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Hanahan D and Weinberg RA: Hallmarks of
cancer: The next generation. Cell. 144:646–674. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Warburg O: On the origin of cancer cells.
Science. 123:309–314. 1956. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Wang C, Wu J, Wang Z, Yang Z, Li Z, Deng
H, Li L, Peng X and Feng M: Glutamine addiction activates
polyglutamine-based nanocarriers delivering therapeutic siRNAs to
orthotopic lung tumor mediated by glutamine transporter SLC1A5.
Biomaterials. 183:77–92. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Vander Heiden MG, Cantley LC and Thompson
CB: Understanding the warburg effect: The metabolic requirements of
cell proliferation. Science. 324:1029–1033. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
DeBerardinis RJ, Lum JJ, Hatzivassiliou G
and Thompson CB: The biology of cancer: Metabolic reprogramming
fuels cell growth and proliferation. Cell Metab. 7:11–20. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Xing Z, Zhang Y, Liang K, Yan L, Xiang Y,
Li C, Hu Q, Jin F, Putluri V, Putluri N, et al: Expression of long
noncoding RNA YIYA promotes glycolysis in breast cancer. Cancer
Res. 78:4524–4532. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Wang X, Xu Y, Wang X, Jiang C, Han S, Dong
K, Shen M and Xu D: LincRNA-p21 suppresses development of human
prostate cancer through inhibition of PKM2. Cell Prolif.
50:e123952017. View Article : Google Scholar
|
|
31
|
Zhang P, Cao L, Fan P, Mei Y and Wu M:
LncRNA-MIF, a c-Myc-activated long non-coding RNA, suppresses
glycolysis by promoting Fbxw7-mediated c-Myc degradation. EMBO Rep.
17:1204–1220. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Lin A, Li C, Xing Z, Hu Q, Liang K, Han L,
Wang C, Hawke DH, Wang S, Zhang Y, et al: The LINK-A lncRNA
activates normoxic HIF1α signalling in triple-negative breast
cancer. Nat Cell Biol. 18:213–224. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Wu M, An J, Zheng Q, Xin X, Lin Z, Li X,
Li H and Lu D: Double mutant P53 (N340Q/L344R) promotes
hepatocarcinogenesis through upregulation of Pim1 mediated by PKM2
and LncRNA CUDR. Oncotarget. 7:66525–66539. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Dröge W: Free radicals in the
physiological control of cell function. Physiol Rev. 82:47–95.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Shiraishi T, Verdone JE, Huang J, Kahlert
UD, Hernandez JR, Torga G, Zarif JC, Epstein T, Gatenby R,
McCartney A, et al: Glycolysis is the primary bioenergetic pathway
for cell motility and cytoskeletal remodeling in human prostate and
breast cancer cells. Oncotarget. 6:130–143. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Peppicelli S, Bianchini F and Calorini L:
Extracellular acidity, a ‘reappreciated’ trait of tumor environment
driving malignancy: Perspectives in diagnosis and therapy. Cancer
Metastasis Rev. 33:823–832. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Gottschalk S, Anderson N, Hainz C,
Eckhardt SG and Serkova NJ: Imatinib (STI571)-mediated changes in
glucose metabolism in human leukemia BCR-ABL-positive cells. Clin
Cancer Res. 10:6661–6668. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Elstrom RL, Bauer DE, Buzzai M, Karnauskas
R, Harris MH, Plas DR, Zhuang H, Cinalli RM, Alavi A, Rudin CM and
Thompson CB: Akt stimulates aerobic glycolysis in cancer cells.
Cancer Res. 64:3892–3899. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Joost HG, Bell GI, Best JD, Birnbaum MJ,
Charron MJ, Chen YT, Doege H, James DE, Lodish HF, Moley KH, et al:
Nomenclature of the GLUT/SLC2A family of sugar/polyol transport
facilitators. Am J Physiol Endocrinol Metab. 282:E974–E976. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Mueckler M and Thorens B: The SLC2 (GLUT)
family of membrane transporters. Mol Aspects Med. 34:121–138. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Wang Y, Zhang X, Wang Z, Hu Q, Wu J, Li Y,
Ren X, Wu T, Tao X, Chen X, et al: LncRNA-p23154 promotes the
invasion-metastasis potential of oral squamous cell carcinoma by
regulating Glut1-mediated glycolysis. Cancer Lett. 434:172–183.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Ellis BC, Graham LD and Molloy PL: CRNDE,
a long non-coding RNA responsive to insulin/IGF signaling,
regulates genes involved in central metabolism. Biochim Biophys
Acta. 1843:372–386. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Kang Y, Zhu X, Xu Y, Tang Q, Huang Z, Zhao
Z, Lu J, Song G, Xu H, Deng C and Wang J: Energy stress-induced
lncRNA HAND2-AS1 represses HIF1α-mediated energy metabolism and
inhibits osteosarcoma progression. Am J Cancer Res. 8:526–537.
2018.PubMed/NCBI
|
|
44
|
Chang L, Xu W, Zhang Y and Gong F: Long
non-coding RNA-NEF targets glucose transportation to inhibit the
proliferation of non-small-cell lung cancer cells. Oncol Lett.
17:2795–2801. 2019.PubMed/NCBI
|
|
45
|
Zhao Y, Liu Y, Lin L, Huang Q, He W, Zhang
S, Dong S, Wen Z, Rao J, Liao W and Shi M: The lncRNA MACC1-AS1
promotes gastric cancer cell metabolic plasticity via AMPK/Lin28
mediated mRNA stability of MACC1. Mol Cancer. 17:692018. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Wolf A, Agnihotri S, Micallef J, Mukherjee
J, Sabha N, Cairns R, Hawkins C and Guha A: Hexokinase 2 is a key
mediator of aerobic glycolysis and promotes tumor growth in human
glioblastoma multiforme. J Exp Med. 208:313–326. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Song J, Wu X, Liu F, Li M, Sun Y, Wang Y,
Wang C, Zhu K, Jia X, Wang B and Ma X: Long non-coding RNA PVT1
promotes glycolysis and tumor progression by regulating miR-497/HK2
axis in osteosarcoma. Biochem Biophys Res Commun. 490:217–224.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Lin YH, Wu MH, Huang YH, Yeh CT, Cheng ML,
Chi HC, Tsai CY, Chung IH, Chen CY and Lin KH: Taurine up-regulated
gene 1 functions as a master regulator to coordinate glycolysis and
metastasis in hepatocellular carcinoma. Hepatology. 67:188–203.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Zheng X, Han H, Liu GP, Ma YX, Pan RL,
Sang LJ, Li RH, Yang LJ, Marks JR, Wang W and Lin A: LncRNA wires
up Hippo and Hedgehog signaling to reprogramme glucose metabolism.
EMBO J. 36:3325–3335. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Noguchi T, Yamada K, Inoue H, Matsuda T
and Tanaka T: The L- and R-type isozymes of rat pyruvate kinase are
produced from a single gene by use of different promoters. J Biol
Chem. 262:14366–14371. 1987. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Noguchi T, Inoue H and Tanaka T: The M1-
and M2-type isozymes of rat pyruvate kinase are produced from the
same gene by alternative RNA splicing. J Biol Chem.
261:13807–13812. 1986. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Mazurek S, Boschek CB, Hugo F and
Eigenbrodt E: Pyruvate kinase type M2 and its role in tumor growth
and spreading. Semin Cancer Biol. 15:300–308. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Bian Z, Zhang J, Li M, Feng Y, Wang X,
Zhang J, Yao S, Jin G, Du J, Han W, et al: LncRNA-FEZF1-AS1
promotes tumor proliferation and metastasis in colorectal cancer by
regulating PKM2 signaling. Clin Cancer Res. 24:4808–4819. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Yang B, Zhang L, Cao Y, Chen S, Cao J, Wu
D, Chen J, Xiong H, Pan Z, Qiu F, et al: Overexpression of lncRNA
IGFBP4-1 reprograms energy metabolism to promote lung cancer
progression. Mol Cancer. 16:1542017. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Feng Y, Xiong Y, Qiao T, Li X, Jia L and
Han Y: Lactate dehydrogenase A: A key player in carcinogenesis and
potential target in cancer therapy. Cancer Med. 7:6124–6136. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Ping W, Senyan H, Li G, Yan C and Long L:
Increased lactate in gastric cancer tumor-infiltrating lymphocytes
is related to impaired T cell function due to miR-34a deregulated
lactate dehydrogenase A. Cell Physiol Biochem. 49:828–836. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Girgis H, Masui O, White NM, Scorilas A,
Rotondo F, Seivwright A, Gabril M, Filter ER, Girgis AH, Bjarnason
GA, et al: Lactate dehydrogenase A is a potential prognostic marker
in clear cell renal cell carcinoma. Mol Cancer. 13:1012014.
View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Chen H, Pei H, Hu W, Ma J, Zhang J, Mao W,
Nie J, Xu C, Li B, Hei TK, et al: Long non-coding RNA CRYBG3
regulates glycolysis of lung cancer cells by interacting with
lactate dehydrogenase A. J Cancer. 9:2580–2588. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Rupaimoole R, Lee J, Haemmerle M, Ling H,
Previs RA, Pradeep S, Wu SY, Ivan C, Ferracin M, Dennison JB, et
al: Long noncoding RNA ceruloplasmin promotes cancer growth by
altering glycolysis. Cell Rep. 13:2395–2402. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Xiang S, Gu H, Jin L, Thorne RF, Zhang XD
and Wu M: LncRNA IDH1-AS1 links the functions of c-Myc and HIF1α
via IDH1 to regulate the Warburg effect. Proc Natl Acad Sci USA.
115:E1465–E1474. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Zhao L, Ji G, Le X, Wang C, Xu L, Feng M,
Zhang Y, Yang H, Xuan Y, Yang Y, et al: Long noncoding RNA
LINC00092 acts in cancer-associated fibroblasts to drive glycolysis
and progression of ovarian cancer. Cancer Res. 77:1369–1382. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Hung CL, Wang LY, Yu YL, Chen HW,
Srivastava S, Petrovics G and Kung HJ: A long noncoding RNA
connects c-Myc to tumor metabolism. Proc Natl Acad Sci USA.
111:18697–18702. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Sodir NM, Swigart LB, Karnezis AN, Hanahan
D, Evan GI and Soucek L: Endogenous Myc maintains the tumor
microenvironment. Genes Dev. 25:907–916. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Semenza GL, Rue EA, Iyer NV, Pang MG and
Kearns WG: Assignment of the hypoxia-inducible factor 1alpha gene
to a region of conserved synteny on mouse chromosome 12 and human
chromosome 14q. Genomics. 34:437–439. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
65
|
Wang GL, Jiang BH, Rue EA and Semenza GL:
Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS
heterodimer regulated by cellular O2 tension. Proc Natl Acad Sci
USA. 92:5510–5514. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
66
|
Peng F, Wang JH, Fan WJ, Meng YT, Li MM,
Li TT, Cui B, Wang HF, Zhao Y, An F, et al: Glycolysis gatekeeper
PDK1 reprograms breast cancer stem cells under hypoxia. Oncogene.
37:1062–1074. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
67
|
Su X, Li G and Liu W: The Long noncoding
RNA cancer susceptibility candidate 9 promotes nasopharyngeal
carcinogenesis via stabilizing HIF1α. DNA Cell Biol. 36:394–400.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
68
|
Jaakkola P, Mole DR, Tian YM, Wilson MI,
Gielbert J, Gaskell SJ, von Kriegsheim A, Hebestreit HF, Mukherji
M, Schofield CJ, et al: Targeting of HIF-alpha to the von
Hippel-Lindau ubiquitylation complex by O2-regulated prolyl
hydroxylation. Science. 292:468–472. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
69
|
Shao W, Wang D, Chiang YT, Ip W, Zhu L, Xu
F, Columbus J, Belsham DD, Irwin DM, Zhang H, et al: The Wnt
signaling pathway effector TCF7L2 controls gut and brain
proglucagon gene expression and glucose homeostasis. Diabetes.
62:789–800. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
70
|
Sethi JK and Vidal-Puig A: Wnt signalling
and the control of cellular metabolism. Biochem J. 427:1–17. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
71
|
Laplante M and Sabatini DM: mTOR signaling
in growth control and disease. Cell. 149:274–293. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
72
|
Malakar P, Stein I, Saragovi A, Winkler R,
Stern-Ginossar N, Berger M, Pikarsky E and Karni R: Long noncoding
RNA MALAT1 regulates cancer glucose metabolism by enhancing
mTOR-mediated translation of TCF7L2. Cancer Res. 79:2480–2493.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
73
|
Aquilano K, Baldelli S, Pagliei B, Cannata
SM, Rotilio G and Ciriolo MR: p53 orchestrates the PGC-1α-mediated
antioxidant response upon mild redox and metabolic imbalance.
Antioxid Redox Signal. 18:386–399. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
74
|
Rajeshkumar NV, Dutta P, Yabuuchi S, de
Wilde RF, Martinez GV, Le A, Kamphorst JJ, Rabinowitz JD, Jain SK,
Hidalgo M, et al: Therapeutic targeting of the Warburg effect in
pancreatic cancer relies on an absence of p53 function. Cancer Res.
75:3355–3364. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
75
|
Greenblatt MS, Feitelson MA, Zhu M,
Bennett WP, Welsh JA, Jones R, Borkowski A and Harris CC: Integrity
of p53 in hepatitis B × antigen-positive and -negative
hepatocellular carcinomas. Cancer Res. 57:426–432. 1997.PubMed/NCBI
|
|
76
|
Feitelson MA, Zhu M, Duan LX and London
WT: Hepatitis B × antigen and p53 are associated in vitro and in
liver tissues from patients with primary hepatocellular carcinoma.
Oncogene. 8:1109–1117. 1993.PubMed/NCBI
|
|
77
|
Patra KC and Hay N: The pentose phosphate
pathway and cancer. Trends Biochem Sci. 39:347–354. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
78
|
Feng J, Ma J, Liu S, Wang J and Chen Y: A
noncoding RNA LINC00504 interacts with c-Myc to regulate tumor
metabolism in colon cancer. J Cell Biochem. 120:14725–14734. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
79
|
Li N and Zhan X and Zhan X: The lncRNA
SNHG3 regulates energy metabolism of ovarian cancer by an analysis
of mitochondrial proteomes. Gynecol Oncol. 150:343–354. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
80
|
Wise DR and Thompson CB: Glutamine
addiction: A new therapeutic target in cancer. Trends Biochem Sci.
35:427–433. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
81
|
Wu MC, Arimura GK and Yunis AA: Mechanism
of sensitivity of cultured pancreatic carcinoma to asparaginase.
Int J Cancer. 22:728–733. 1978. View Article : Google Scholar : PubMed/NCBI
|
|
82
|
Eagle H: The minimum vitamin requirements
of the L and HeLa cells in tissue culture, the production of
specific vitamin deficiencies, and their cure. J Exp Med.
102:595–600. 1955. View Article : Google Scholar : PubMed/NCBI
|
|
83
|
Lai HS, Lee JC, Lee PH, Wang ST and Chen
WJ: Plasma free amino acid profile in cancer patients. Semin Cancer
Biol. 15:267–276. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
84
|
Hsieh AL, Walton ZE, Altman BJ, Stine ZE
and Dang CV: MYC and metabolism on the path to cancer. Semin Cell
Dev Biol. 43:11–21. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
85
|
Wu G, Fang YZ, Yang S, Lupton JR and
Turner ND: Glutathione metabolism and its implications for health.
J Nutr. 134:489–492. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
86
|
Yang C, Ko B, Hensley CT, Jiang L, Wasti
AT, Kim J, Sudderth J, Calvaruso MA, Lumata L, Mitsche M, et al:
Glutamine oxidation maintains the TCA cycle and cell survival
during impaired mitochondrial pyruvate transport. Mol Cell.
56:414–424. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
87
|
Yu Y, Yu X, Fan C, Wang H, Wang R, Feng C
and Guan H: Targeting glutaminase-mediated glutamine dependence in
papillary thyroid cancer. J Mol Med (Berl). 96:777–790. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
88
|
Li HJ, Li X, Pang H, Pan JJ, Xie XJ and
Chen W: Long non-coding RNA UCA1 promotes glutamine metabolism by
targeting miR-16 in human bladder cancer. Jpn J Clin Oncol.
45:1055–1063. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
89
|
Kitayama K, Yashiro M, Morisaki T, Miki Y,
Okuno T, Kinoshita H, Fukuoka T, Kasashima H, Masuda G, Hasegawa T,
et al: Pyruvate kinase isozyme M2 and glutaminase might be
promising molecular targets for the treatment of gastric cancer.
Cancer Sci. 108:2462–2469. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
90
|
Lampa M, Arlt H, He T, Ospina B, Reeves J,
Zhang B, Murtie J, Deng G, Barberis C, Hoffmann D, et al:
Glutaminase is essential for the growth of triple-negative breast
cancer cells with a deregulated glutamine metabolism pathway and
its suppression synergizes with mTOR inhibition. PLoS One.
12:e01850922017. View Article : Google Scholar : PubMed/NCBI
|
|
91
|
Deng SJ, Chen HY, Zeng Z, Deng S, Zhu S,
Ye Z, He C, Liu ML, Huang K, Zhong JX, et al: Nutrient
stress-dysregulated antisense lncRNA GLS-AS impairs GLS-mediated
metabolism and represses pancreatic cancer progression. Cancer Res.
79:1398–1412. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
92
|
Liu L, Cui S, Wan T, Li X, Tian W, Zhang
R, Luo L and Shi Y: Long non-coding RNA HOTAIR acts as a competing
endogenous RNA to promote glioma progression by sponging
miR-126-5p. J Cell Physiol. 233:6822–6831. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
93
|
Ge Y, Yan X, Jin Y, Yang X, Yu X, Zhou L,
Han S, Yuan Q and Yang M: MiRNA-192 (corrected) and miRNA-204
Directly Suppress lncRNA HOTTIP and Interrupt GLS1-mediated
glutaminolysis in hepatocellular carcinoma. PLoS Genet.
11:e10057262015. View Article : Google Scholar : PubMed/NCBI
|
|
94
|
Luan W, Zhang X, Ruan H, Wang J and Bu X:
Long noncoding RNA OIP5-AS1 acts as a competing endogenous RNA to
promote glutamine catabolism and malignant melanoma growth by
sponging miR-217. J Cell Physiol. Feb 18–2019.(Epub ahead of
print). doi: 10.1002/jcp.28335. View Article : Google Scholar
|
|
95
|
Zhuo ZJ, Zhang R, Zhang J, Zhu J, Yang T,
Zou Y, He J and Xia H: Associations between lncRNA MEG3
polymorphisms and neuroblastoma risk in Chinese children. Aging
(Albany NY). 10:481–491. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
96
|
Li S, Lin A, Han D, Zhou H, Cheng J, Zhang
J, Fu W, Zhuo Z and He J: LINC00673 rs11655237 C>T and
susceptibility to Wilms tumor: A five-center case-control study. J
Gene Med. 21:e31332019. View Article : Google Scholar : PubMed/NCBI
|
|
97
|
Li Y, Zhuo ZJ, Zhou H, Liu J, Liu Z, Zhang
J, Cheng J, Li S, Zhou H, Zhou R, et al: Additional data support
the role of LINC00673 rs11655237 C>T in the development of
neuroblastoma. Aging (Albany NY). 11:2369–2377. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
98
|
Hapala I, Marza E and Ferreira T: Is fat
so bad? Modulation of endoplasmic reticulum stress by lipid droplet
formation. Biol Cell. 103:271–285. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
99
|
Phillips CM, Goumidi L, Bertrais S, Field
MR, Cupples LA, Ordovas JM, Defoort C, Lovegrove JA, Drevon CA,
Gibney MJ, et al: Gene-nutrient interactions with dietary fat
modulate the association between genetic variation of the ACSL1
gene and metabolic syndrome. J Lipid Res. 51:1793–1800. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
100
|
Zhou W, Tu Y, Simpson PJ and Kuhajda FP:
Malonyl-CoA decarboxylase inhibition is selectively cytotoxic to
human breast cancer cells. Oncogene. 28:2979–2987. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
101
|
Núñez V, Alameda D, Rico D, Mota R,
Gonzalo P, Cedenilla M, Fischer T, Boscá L, Glass CK, Arroyo AG and
Ricote M: Retinoid X receptor alpha controls innate inflammatory
responses through the up-regulation of chemokine expression. Proc
Natl Acad Sci USA. 107:10626–10631. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
102
|
Cui M, Xiao Z, Wang Y, Zheng M, Song T,
Cai X, Sun B, Ye L and Zhang X: Long noncoding RNA HULC modulates
abnormal lipid metabolism in hepatoma cells through an
miR-9-mediated RXRA signaling pathway. Cancer Res. 75:846–857.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
103
|
Christensen LL, True K, Hamilton MP,
Nielsen MM, Damas ND, Damgaard CK, Ongen H, Dermitzakis E, Bramsen
JB, Pedersen JS, et al: SNHG16 is regulated by the Wnt pathway in
colorectal cancer and affects genes involved in lipid metabolism.
Mol Oncol. 10:1266–1282. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
104
|
Gong J, Shen S, Yang Y, Qin S, Huang L,
Zhang H, Chen L, Chen Y, Li S, She S, et al: Inhibition of FASN
suppresses migration, invasion and growth in hepatoma carcinoma
cells by deregulating the HIF-1α/IGFBP1 pathway. Int J Oncol.
50:883–892. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
105
|
Jiang Y, Yin X, Wu L, Qin Q and Xu J:
MAPK/P53-mediated FASN expression in bone tumors. Oncol Lett.
13:4035–4038. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
106
|
Tao BB, He H, Shi XH, Wang CL, Li WQ, Li
B, Dong Y, Hu GH, Hou LJ, Luo C, et al: Up-regulation of USP2a and
FASN in gliomas correlates strongly with glioma grade. J Clin
Neurosci. 20:717–720. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
107
|
Lu C, Ma J and Cai D: Increased HAGLR
expression promotes non-small cell lung cancer proliferation and
invasion via enhanced de novo lipogenesis. Tumour Biol. Apr
26–2017.(Epub ahead of print). doi:
org/10.1177/1010428317697574.
|
|
108
|
Ma DD, Yuan LL and Lin LQ: LncRNA HOTAIR
contributes to the tumorigenesis of nasopharyngeal carcinoma via
up-regulating FASN. Eur Rev Med Pharmacol Sci. 21:5143–5152.
2017.PubMed/NCBI
|
|
109
|
Bolsoni-Lopes A and Alonso-Vale MI:
Lipolysis and lipases in white adipose tissue-an update. Arch
Endocrinol Metab. 59:335–342. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
110
|
Liu X, Liang Y, Song R, Yang G, Han J, Lan
Y, Pan S, Zhu M, Liu Y, Wang Y, et al: Long non-coding RNA
NEAT1-modulated abnormal lipolysis via ATGL drives hepatocellular
carcinoma proliferation. Mol Cancer. 17:902018. View Article : Google Scholar : PubMed/NCBI
|
|
111
|
Shang C, Wang W, Liao Y, Chen Y, Liu T, Du
Q, Huang J, Liang Y, Liu J, Zhao Y, et al: LNMICC promotes nodal
metastasis of cervical cancer by reprogramming fatty acid
metabolism. Cancer Res. 78:877–890. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
112
|
Li D, Cheng M, Niu Y, Chi X, Liu X, Fan J,
Fan H, Chang Y and Yang W: Identification of a novel human long
non-coding RNA that regulates hepatic lipid metabolism by
inhibiting SREBP-1c. Int J Biol Sci. 13:349–357. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
113
|
Kulsum S, Sudheendra HV, Pandian R,
Ravindra DR, Siddappa G, R N, Chevour P, Ramachandran B, Sagar M,
Jayaprakash A, et al: Cancer stem cell mediated acquired
chemoresistance in head and neck cancer can be abrogated by
aldehyde dehydrogenase 1 A1 inhibition. Mol Carcinog. 56:694–711.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
114
|
Yao Z, Jones AW, Fassone E, Sweeney MG,
Lebiedzinska M, Suski JM, Wieckowski MR, Tajeddine N, Hargreaves
IP, Yasukawa T, et al: PGC-1β mediates adaptive chemoresistance
associated with mitochondrial DNA mutations. Oncogene.
32:2592–2600. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
115
|
Zhang Y, Zeng S, Ma J, Deng G, Qu Y, Guo C
and Shen H: Nestin overexpression in hepatocellular carcinoma
associates with epithelial-mesenchymal transition and
chemoresistance. J Exp Clin Cancer Res. 35:1112016. View Article : Google Scholar : PubMed/NCBI
|
|
116
|
McNeil EM and Melton DW: DNA repair
endonuclease ERCC1-XPF as a novel therapeutic target to overcome
chemoresistance in cancer therapy. Nucleic Acids Res.
40:9990–10004. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
117
|
Kim M, Jung JY, Choi S, Lee H, Morales LD,
Koh JT, Kim SH, Choi YD, Choi C, Slaga TJ, et al: GFRA1 promotes
cisplatin-induced chemoresistance in osteosarcoma by inducing
autophagy. Autophagy. 13:149–168. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
118
|
Shi H, Li K, Feng J, Liu G, Feng Y and
Zhang X: LncRNA-DANCR Interferes with miR-125b-5p/HK2 axis to
desensitize colon cancer cells to cisplatin vis activating
anaerobic glycolysis. Front Oncol. 10:10342020. View Article : Google Scholar : PubMed/NCBI
|
|
119
|
Zheng ZQ, Li ZX, Guan JL, Liu X, Li JY,
Chen Y, Lin L, Kou J, Lv JW, Zhang LL, et al: Long noncoding RNA
TINCR-mediated regulation of acetyl-coa metabolism promotes
nasopharyngeal carcinoma progression and chemoresistance. Cancer
Res. 80:5174–5188. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
120
|
He W, Liang B, Wang C, Li S, Zhao Y, Huang
Q, Liu Z, Yao Z, Wu Q, Liao W, et al: MSC-regulated lncRNA
MACC1-AS1 promotes stemness and chemoresistance through fatty acid
oxidation in gastric cancer. Oncogene. 38:4637–4654. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
121
|
Wen JF, Jiang YQ, Li C, Dai XK, Wu T and
Yin WZ: LncRNA-SARCC sensitizes osteosarcoma to cisplatin through
the miR-143-mediated glycolysis inhibition by targeting Hexokinase
2. Cancer Biomark. 28:231–246. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
122
|
Wang T, Fahrmann JF, Lee H, Li YJ,
Tripathi SC, Yue C, Zhang C, Lifshitz V, Song J, Yuan Y, et al:
JAK/STAT3-Regulated fatty acid beta-oxidation is critical for
breast cancer stem cell self-renewal and chemoresistance. Cell
Metab. 27:136–150.e5. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
123
|
Hoy SM: Patisiran: First global approval.
Drugs. 78:1625–1631. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
124
|
Yang J, Guo Y, Seo W, Zhang R, Lu C, Wang
Y, Luo L, Paul B, Yan W, Saxena D and Li X: Targeting cellular
metabolism to reduce head and neck cancer growth. Sci Rep.
9:49952019. View Article : Google Scholar : PubMed/NCBI
|
|
125
|
Elgogary A, Xu Q, Poore B, Alt J,
Zimmermann SC, Zhao L, Fu J, Chen B, Xia S, Liu Y, et al:
Combination therapy with BPTES nanoparticles and metformin targets
the metabolic heterogeneity of pancreatic cancer. Proc Natl Acad
Sci USA. 113:E5328–E5336. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
126
|
Qing L and Qing W: Hypoxia inducible
factor 1 inhibitors for cancer therapy. Minerva Chir. 74:442–444.
2019. View Article : Google Scholar : PubMed/NCBI
|
